Evidence map›Paper›PMID 30023290›Full record

ArticleMolecular genetics and metabolism reports2018

Hyperphosphatasia with mental retardation syndrome, expanded phenotype of

Ruqaiah Altassan, Stephanie Fox, Chantal Poulin, Daniela Buhas

Abstract readCase Reports
In one paragraph

Article in Molecular genetics and metabolism reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Cells · 2020
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruqaiah AltassanDepartment of Medical Genetics, Montreal Children's Hospital, McGill University Health Center, Montreal, Quebec, Canada.
Stephanie FoxDepartment of Medical Genetics, Montreal Children's Hospital, McGill University Health Center, Montreal, Quebec, Canada.
Chantal PoulinDepartment of Pediatric, Division of Neurology, Montreal Children's Hospital, McGill University Health Center, Montreal, Quebec, Canada.
Daniela BuhasDepartment of Medical Genetics, Montreal Children's Hospital, McGill University Health Center, Montreal, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypomorphic mutations in six different genes involved in the glycosylphosphatidylinositol (GPI) biogenesis pathway are linked to Mabry syndrome (hyperphosphatasia with mental retardation syndrome, HPMRS). This report on the third affected family with a HPMRS phenotype caused by mutations in

Indexed as

ALP, alkaline phosphataseCHIME, ocular colobomas, heart defect, ichthyosis, mental retardation, and abnormal ears or epilepsyCHIME syndromeCSS, Coffin-Siris syndromeGPI biogenesisGPI, glycosylphosphatidylinositolHPMRS, hyperphosphatasia with mental retardation syndromeHyperphosphatasia mental retardation syndrome (HPMRS)Mabry syndromePIGL genePIGL, phosphatidylinositol glycan anchor biosynthesis class L

Identifiers

PMID30023290
PMCPMC6047459

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.